Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Relating to the authority of a political subdivision to spend public money in support of certain professional associations that promote or implement diversity, equity, and inclusion initiatives.
Relating to the eligibility of children and other dependents of certain military personnel or veterans for tuition and fee exemptions at public institutions of higher education.
Relating to prohibiting a public institution of higher education from providing funding to a student organization that promotes diversity, equity, and inclusion initiatives.
Relating to prohibited retaliation against a physician or health care provider for reporting certain violations or taking certain actions with respect to the provision of health care services; providing a civil remedy.